121 research outputs found
Volumineux Mélanome Malin De La Conjonctive Multi Récidivant À Propos d’un Cas
Melanoma of the conjunctiva is a tumor that develops from the conjunctival melenocytes. It often reoccurs even after several surgical removals. The authors present the case of a 45 years old woman who was at first seen in our outpatient clinic with a spitz naevus of the conjunctiva of the right eye since more than 20 years ago. This naevus which was excised twice and then the eye enucleated underwent malignant transformation into a voluminous multi-recidivant malignant melanoma weighing after surgical removal 350g and measures 6x12x5cm
Efficacy of Artesunate + Sulfamethoxypyrazine/Pyrimethamine versus Praziquantel in the Treatment of Schistosoma haematobium in Children
BACKGROUND:This study was conducted to determine the efficacy of the antimalarial artemisinin-based combination therapy (ACT) artesunate +sulfamethoxypyrazine/pyrimethamine (As+SMP), administered in doses used for malaria, to treat Schistosoma haematobium in school aged children. METHODOLOGY/PRINCIPAL FINDINGS:The study was conducted in Djalakorodji, a peri-urban area of Bamako, Mali, using a double blind setup in which As+SMP was compared with praziquantel (PZQ). Urine samples were examined for Schistosoma haematobium on days -1, 0, 28 and 29. Detection of haematuria, and haematological and biochemical exams were conducted on day 0 and day 28. Clinical exams were performed on days 0, 1, 2, and 28. A total of 800 children were included in the trial. The cure rate obtained without viability testing was 43.9% in the As+SMP group versus 53% in the PZQ group (Chi(2) = 6.44, p = 0.011). Egg reduction rates were 95.6% with PZQ in comparison with 92.8% with As+SMP, p = 0.096. The proportion of participants who experienced adverse events related to the medication was 0.5% (2/400) in As+SMP treated children compared to 2.3% (9/399) in the PZQ group (p = 0.033). Abdominal pain and vomiting were the most frequent adverse events in both treatment arms. All adverse events were categorized as mild. CONCLUSIONS/SIGNIFICANCE:The study demonstrates that PZQ was more effective than As+SMP for treating Schistosoma haematobium. However, the safety and tolerability profile of As+SMP was similar to that seen with PZQ. Our findings suggest that further investigations seem justifiable to determine the dose/efficacy/safety pattern of As+SMP in the treatment of Schistosoma infections. TRIAL REGISTRATION:ClinicalTrials.gov NCT00510159
Maladie de Lapeyronie: Aspects cliniques et thérapeutiques à propos de 17 cas
Buts: rapporter les aspects cliniques et thérapeutiques de la maladie de Lapeyronie (MLP).Matériel et méthodes: étude descriptive monocentrique recrutant 17 cas de MLP dans un service d’urologie au Sénégal entre janvier et décembre 2012. L’âge des patients, les motifs de consultation, le délai de consultation, l’examen des plaques de fibrose, le degré de courbure, le traitement et ses résultats ont été analysés.Résultats: l’âge moyen était de 58,2 ans (33 et 80 ans). La courbure était la plainte la plus observée (13 patients/17) et isolée chez 4 patients. La douleur pénienne était observée chez 4 patients et la dysérection chez 7 patients. Le délai de consultation moyen était de 21,2 mois (1 et 72 mois). Le grand axe moyen des plaques de fibrose était 2,8 cm (0,5 et 7,5 cm). Le degré de courbure de la verge moyen était de 31,6 (0 et 95). Neuf patients ont rec¸u un traitement à base de vitamine E et des infiltrations de corticoïdes dans la plaque. Il a été efficace chez 3 patients vus à la phase inflammatoire. Un redressement satisfaisant de verge par plicature de l’albuginée des corps caverneux selon Nesbit a été réalisée chez 5 malades en phase de séquelle. Trois patients n’ont pas pu être opérés.Conclusion: la MLP a une faible prévalence et la plupart des patients consultent en phase de séquelle. Le traitement médical a été efficace à la phase inflammatoire et la chirurgie a permis de régler la courbureMots Clés: maladie de Lapeyronie; douleur; courbure; dysfonction érectile; Sénéga
Cancer de la prostate localisé à haut risque de récidive:résultats de la prise charge
No Abstract
Biannual versus annual mass azithromycin distribution and malaria seroepidemiology among preschool children in Niger: a sub-study of a cluster randomized trial.
BACKGROUND: Biannual mass azithromycin administration to preschool children reduces all-cause mortality, but the mechanism for the effect is not understood. Azithromycin has activity against malaria parasites, and malaria is a leading cause of child mortality in the Sahel. The effect of biannual versus annual azithromycin distribution for trachoma control on serological response to merozoite surface protein 1 (MSP-119), a surrogate for malaria incidence, was evaluated among children in Niger. METHODS: Markers of malaria exposure were measured in two arms of a factorial randomized controlled trial designed to evaluate targeted biannual azithromycin distribution to children under 12 years of age compared to annual azithromycin to the entire community for trachoma control (N = 12 communities per arm). Communities were treated for 36 months (6 versus 3 distributions). Dried blood spots were collected at 36 months among children ages 1-5 years, and MSP-119 antibody levels were assessed using a bead-based multiplex assay to measure malaria seroprevalence. RESULTS: Antibody results were available for 991 children. MSP-119 seropositivity was 62.7% in the biannual distribution arm compared to 68.7% in the annual arm (prevalence ratio 0.91, 95% CI 0.83 to 1.00). Mean semi-quantitative antibody levels were lower in the biannual distribution arm compared to the annual arm (mean difference - 0.39, 95% CI - 0.05 to - 0.72). CONCLUSIONS: Targeted biannual azithromycin distribution was associated with lower malaria seroprevalence compared to that in a population that received annual distribution. Trial Registration Clinicaltrials.gov NCT00792922
A qualitative study of women’s and health providers’ attitudes and acceptability of mistreatment during childbirth in health facilities in Guinea
Transcriptomic evidence for modulation of host inflammatory responses during febrile Plasmodium falciparum malaria
Identifying molecular predictors and mechanisms of malaria disease is important for understanding how Plasmodium falciparum malaria is controlled. Transcriptomic studies in humans have so far been limited to retrospective analysis of blood samples from clinical cases. In this prospective, proof-of-principle study, we compared whole-blood RNA-seq profiles at pre-and post-infection time points from Malian adults who were either asymptomatic (n = 5) or febrile (n = 3) during their first seasonal PCR-positive P. falciparum infection with those from malaria-naïve Dutch adults after a single controlled human malaria infection (n = 5). Our data show a graded activation of pathways downstream of pro-inflammatory cytokines, with the highest activation in malaria-naïve Dutch individuals and significantly reduced activation in malaria-experienced Malians. Newly febrile and asymptomatic infections in Malians were statistically indistinguishable except for genes activated by pro-inflammatory cytokines. The combined data provide a molecular basis for the development of a pyrogenic threshold as individuals acquire immunity to clinical malaria
Diagnostic Accuracy of a Prototype Point-of-Care Test for Ocular Chlamydia trachomatis under Field Conditions in The Gambia and Senegal
Trachoma, caused by infection of the eye with the bacterium Chlamydia trachomatis, is the leading infectious cause of blindness and is associated with poverty. Antibiotic treatment of all community members is one of the recommended control strategies for trachoma. However, in places where the prevalence of clinical signs is low, C. trachomatis eye infection is often absent. Laboratory testing for C. trachomatis infection by polymerase chain reaction (PCR) is highly sensitive but expensive and requires well-trained staff. A simple point-of-care (POC) test that can be used in trachoma-affected communities could help trachoma control efforts. We evaluated a POC test for C. trachomatis eye infection. Children under 10 years of age were screened for clinical signs of trachoma and C. trachomatis eye infection. The POC test result was compared with laboratory PCR test results. The POC test detected just over half of PCR test positives correctly. However, the POC test tended to give false-positive results in hot and dry conditions, which is the typical environment of trachoma. The POC test requires high specificity since it would be used to make treatment decisions at the community level. Therefore, its present format requires improvement before it can be utilized in trachoma control
- …